fig1
Figure 1. Chemical structure of PPT (A); FDA-approved derivatives etoposide, teniposide, and etopophos (B); Structure-activity relationships pertaining to PPT (C); Timeline of FDA-approved landmark nanomedicines for cancer treatment (D).
Microstructures
ISSN 2770-2995 (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/microstructures
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
